• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[不同肺部疾病患者血清中KL-6和SP-D的临床研究]

[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].

作者信息

Sugimoto H, Okada E, Hashimoto N, Suzuki S, Yoshida H, Totani Y, Ameshima S, Ishizaki T, Miyamori I

机构信息

Department of Clinical Laboratory, Fukui Medical University.

出版信息

Rinsho Byori. 2000 Jun;48(6):554-60.

PMID:10897675
Abstract

It has been reported that serum levels of KL-6 and surfactant protein D(SP-D) can be useful indicators for interstitial pneumonia(IP). In the present study, we evaluated the clinical significance of KL-6 and SP-D by measuring the serum levels of patients with various pulmonary diseases by enzyme-linked immunosorbent assay. Serum levels of KL-6 in patients with idiopathic interstitial pneumonia(IIP), collagen disease with interstitial pneumonia(CDIP), lung cancer(LC) and LC with idiopathic interstitial pneumonia were significantly higher than of those in healthy controls. Moreover, serum levels of KL-6 were significantly higher in patients with active IP than in those with inactive IP. Serum levels of SP-D in patients with IIP and CDIP were significantly higher than of those in healthy controls. When a cut-off level of KL-6 or SP-D in sera was defined as a value of healthy controls representing the means + 2SD, the serum KL-6 positive diagnostic rate for IP(79.2%) was higher than that of SP-D(66.7%). The SP-D positive diagnostic rate for lung diseases other than IP(11.6%) was lower than that of KL-6(34.9%). The serum concentration of KL-6 in patients with the pulmonary diseases significantly correlated with that of SP-D. These findings suggest that KL-6 may be superior in the sensitivity of IP and can be used to evaluate the disease activity of IP. In addition, SP-D may be more specific for IP than KL-6.

摘要

据报道,血清KL-6和表面活性蛋白D(SP-D)水平可作为间质性肺炎(IP)的有用指标。在本研究中,我们通过酶联免疫吸附测定法测量各种肺部疾病患者的血清水平,评估了KL-6和SP-D的临床意义。特发性间质性肺炎(IIP)、伴有间质性肺炎的胶原病(CDIP)、肺癌(LC)以及伴有特发性间质性肺炎的LC患者的血清KL-6水平显著高于健康对照组。此外,活动性IP患者的血清KL-6水平显著高于非活动性IP患者。IIP和CDIP患者的血清SP-D水平显著高于健康对照组。当将血清中KL-6或SP-D的临界值定义为代表健康对照者均值+2SD的值时,IP的血清KL-6阳性诊断率(79.2%)高于SP-D(66.7%)。非IP肺部疾病的SP-D阳性诊断率(11.6%)低于KL-6(34.9%)。肺部疾病患者的血清KL-6浓度与SP-D浓度显著相关。这些发现表明,KL-6在IP的敏感性方面可能更具优势,可用于评估IP的疾病活动度。此外,SP-D对IP的特异性可能比KL-6更高。

相似文献

1
[The clinical study on KL-6 and SP-D in sera of patients with various pulmonary diseases].[不同肺部疾病患者血清中KL-6和SP-D的临床研究]
Rinsho Byori. 2000 Jun;48(6):554-60.
2
[Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].血清KL-6和SP-D在弥漫性结缔组织病患者间质性肺疾病诊断与治疗中的临床意义
Ryumachi. 2003 Feb;43(1):19-28.
3
Clinical significance of surfactant protein D as a serum marker for evaluating pulmonary fibrosis in patients with systemic sclerosis.表面活性蛋白D作为评估系统性硬化症患者肺纤维化血清标志物的临床意义。
Arthritis Rheum. 2001 Jun;44(6):1363-9. doi: 10.1002/1529-0131(200106)44:6<1363::AID-ART229>3.0.CO;2-5.
4
KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.KL-6作为胶原病相关间质性肺炎的一种新型血清标志物。
J Rheumatol. 2000 May;27(5):1164-70.
5
Comparative study of KL-6, surfactant protein-A, surfactant protein-D, and monocyte chemoattractant protein-1 as serum markers for interstitial lung diseases.KL-6、表面活性蛋白-A、表面活性蛋白-D和单核细胞趋化蛋白-1作为间质性肺疾病血清标志物的比较研究
Am J Respir Crit Care Med. 2002 Feb 1;165(3):378-81. doi: 10.1164/ajrccm.165.3.2107134.
6
[Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].[血清标志物KL-6和SP-D用于评估结缔组织病相关间质性肺炎]
Ryumachi. 2003 Feb;43(1):11-8.
7
[Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].[血清表面活性蛋白A和D在特发性间质性肺炎中的临床意义]
Nihon Kyobu Shikkan Gakkai Zasshi. 1996 Dec;34 Suppl:181-5.
8
[Significance of serum surfactant protein-D (SP-D) level in patients with pulmonary tuberculosis].[血清表面活性蛋白-D(SP-D)水平在肺结核患者中的意义]
Kekkaku. 1998 Oct;73(10):585-90.
9
A case of Wilson-Mikity syndrome with high serum KL-6 levels.
J Perinatol. 2003 Jan;23(1):56-8. doi: 10.1038/sj.jp.7210830.
10
Comparative study of serum surfactant protein-D and KL-6 concentrations in patients with systemic sclerosis as markers for monitoring the activity of pulmonary fibrosis.系统性硬化症患者血清表面活性蛋白-D和KL-6浓度作为监测肺纤维化活动标志物的比较研究。
J Rheumatol. 2004 Jun;31(6):1112-20.

引用本文的文献

1
Identification and characterization of lysophosphatidylcholine 14:0 as a biomarker for drug-induced lung disease.鉴定和表征 14:0 溶血磷脂酰胆碱作为药物性肺病的生物标志物。
Sci Rep. 2022 Nov 17;12(1):19819. doi: 10.1038/s41598-022-24406-z.
2
A Case of Radiation Fibrosis Appearing as Mass-Like Consolidation after SBRT with Elevation of Serum CEA.1例立体定向体部放疗后出现类似肿块样实变并伴有血清癌胚抗原升高的放射性纤维化病例。
Case Rep Med. 2010;2010:986706. doi: 10.1155/2010/986706. Epub 2010 Jun 6.